2011-02-07 18:32:23 UTC

Rifaximin Improves Driving in Hepatic Encephalopathy

Feb. 7, 2011

Doctors found that in patients with cirrhosis and minimal hepatic encephalopathy, driving performance significantly improved after treatment with rifaximin.

Patients with cirrhosis and minimal hepatic encephalopathy have driving difficulties, but the effects of therapy on driving performance are unclear. In a study appearing in Gastroenterology, doctors concluded that patients with minimal hepatic encephalopathy significantly improve driving simulator performance after treatment with rifaximin, compared with placebo.

Gastroenterology; 2011: 140(2): 478-87

More on Cirrhosis

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Blog: Diagnosis, Pathogenesis and Treatment of Hepatorenal Syndrome in Patients With Cirrhosis

Jan. 30, 2018

New concepts and developments for diagnosis and assessment of renal function in patients with cirrhosis. Read more on the AGA Journals Blog.

Image Challenge: Cullen's Sign

Jan. 22, 2018

What caused a 56-year-old man with a previous history of cirrhosis to present with a large volume of ascites and periumbilical ecchymosis?